Dimethyloxaloylglycine-stimulated human bone marrow mesenchymal stem cell-derived exosomes enhance bone regeneration through angiogenesis by targeting the AKT/mTOR pathway.
Bo LiangJia-Ming LiangJia-Ning DingJia XuJian-Guang XuYi-Min ChaiPublished in: Stem cell research & therapy (2019)
Low doses of DMOG trigger exosomes to exert enhanced proangiogenic activity in cell-free therapeutic applications.